InvestorsObserver
×
News Home

Lantern Pharma Inc (LTRN) is higher by 19.70% in a Week, Should You Accumulate?

Friday, November 17, 2023 11:03 AM | InvestorsObserver Analysts

Mentioned in this article

Lantern Pharma Inc (LTRN) is higher by 19.70% in a Week, Should You Accumulate?

Lantern Pharma Inc (LTRN) is around the top of the Biotechnology industry according to InvestorsObserver. LTRN received an overall rating of 58, which means that it scores higher than 58 percent of all stocks. Lantern Pharma Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 51 out of the 148 industries.

Overall Score - 58
LTRN has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on LTRN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Lantern Pharma Inc Stock Today?

Lantern Pharma Inc (LTRN) stock is up 2.62% while the S&P 500 has fallen -0.03% as of 11:00 AM on Friday, Nov 17. LTRN is higher by $0.10 from the previous closing price of $3.85 on volume of 2,940 shares. Over the past year the S&P 500 is higher by 14.20% while LTRN has fallen -29.46%. LTRN lost -$1.40 per share the over the last 12 months. Click Here to get the full Stock Report for Lantern Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App